Furthermore, PKR initially facilitated tau hyperphosphorylation, which is independent of PKR-mediated downstream activation of GSK-3β or neuroinflammation in AD and other tauopathies (Reimer et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.